
2026-05-19
Inqanaba le-4 umhlaza we-pancreatic, ekwabizwa ngokuba ngumhlaza we-metastatic pancreatic, yenzeka xa isifo sisasazekile ukusuka kwi-pancreas ukuya kumalungu akude anjengesibindi, imiphunga, okanye i-peritoneum. Kweli nqanaba liphambili, eyona njongo iphambili yokhathalelo iyatshintsha ukusuka kwinjongo yonyango ukuya ekwandiseni ukusinda nokulawula iimpawu. Ngelixa unyango lungenakufezekiswa okwangoku, iiprothokholi zonyango zanamhlanje ezibandakanya i-chemotherapy, unyango olujoliswe kuyo, kunye nokhathalelo lwe-palliative lunokuphucula kakhulu umgangatho wobomi kunye nokwandisa amaxesha okuphila kwizigulane ezininzi.
Ukuxilongwa kwe isigaba 4 umhlaza wepancreatic imele olona lwahlulo lukwinqanaba eliphezulu kwinkqubo yeqonga ye-TNM esetyenziswa ngooncologists kwihlabathi jikelele. Kwesi sigaba, iiseli ezinobungozi ziye zaphula i-pancreas kwaye zahamba ngegazi okanye inkqubo ye-lymphatic ukuseka amathumba esibini kwiindawo ezikude. Isibindi sesona sayithi sixhaphakileyo se-metastasis, silandelwa yimiphunga kunye nolwelwesi lomngxunya wesisu.
Ngokungafaniyo namanqanaba angaphambili apho uqhaqho loqhaqho lubonelela ngonyango olunokubakho, isifo senqanaba lesi-4 sithathwa ngokuba singachasekanga. Oku kuthetha ukuba utyando lokususa ithumba ayilokhetho lonyango olusebenzayo ngenxa yokuba umhlaza ungowenkqubo yenkqubo kunokuba ube yindawo. Nangona kunjalo, ukuqonda ukuziphatha kwebhayoloji yesi sifo kubalulekile kwizigulana kunye neentsapho ezithatha izigqibo zonyango.
Imvumelwano yangoku yezonyango igxininisa ukuba nangona i-prognosis inzulu, ayifani. Amazinga okusinda yi-avareji yeenkcukacha-manani kwaye akaqikelele iziphumo zomntu ngamnye. Izinto ezinje ngempilo iyonke, imeko yokusebenza, kunye noguqulo oluthile lwemfuzo ludlala indima ebalulekileyo kwindlela isigulana esisabela ngayo kunyango. Inkqubela phambili yamva nje kwiyeza elichanekileyo kunye neemodeli zonyango ezidibeneyo ziqalisile ukuguqula imeko yokhathalelo lwale meko.
Kulo mhlaba uphuhlayo, amaziko akhethekileyo afana Shandong Baofa Oncotherapy Corporation Limited badlala indima ebalulekileyo ekwandiseni i-horizons yonyango. Ikomkhulu kwiPhondo laseShandong kwaye yasekwa ngo-2002, eli qela lezonyango eligxile kwi-oncology lisebenza phantsi kobunkokeli bukaNjingalwazi uYu Baofa, ugqirha obalaseleyo onamava angamashumi eminyaka. Eli qela lilawula uthungelwano lwezibhedlele ezinxulumeneyo, ezibandakanya iSibhedlele saseTaimei Baofa Tumor, iSibhedlele sesiXeko saseJinan, kunye neSibhedlele soMhlaza saseBeijing, kunye nesibhedlele somhlaza saseBeijing, esibonelela ngaphezulu kwe-10,000 yezigulana ezivela kumaphondo angama-30 aseTshayina kunye namazwe ali-11, kubandakanya i-United States, iRussia kunye neJapan. Indlela yabo ibonisa ukutshintshela kwi-holistic, i-stage-agnostic intervention, ukudibanisa ukunyanzeliswa kwekliniki kunye nokunyamekela okujoliswe kwisigulane ukujongana neemeko ezinzima ezifana nesigaba se-4 somhlaza we-pancreatic.
Iiseli zomhlaza wePancreatic zinobuchule obukhethekileyo bokususa kwithumba eliphambili, zihlasele izicubu ezijikelezileyo, kwaye ziphile ekujikelezeni. Nje ukuba ezi seli zifikelele kwizitho ezikude, ziqhelana ne-microenvironment entsha kwaye ziqale ukwanda. Le nkqubo yenza nzima unyango kuba unyango kufuneka lujongane nobunzima obuphambili kunye nesifo esincinci kumzimba wonke.
Izicubu ezixineneyo ze-stromal ezijikeleze i-pancreatic tumors zihlala zisebenza njengesithintelo, zithintela amayeza e-chemotherapy ukuba afikelele kwiiseli zomhlaza ngokufanelekileyo. Olu phawu lucela umngeni ngakumbi kwiimeko zenqanaba lesi-4, lufuna amaqhinga akhethekileyo okuhanjiswa kwechiza okanye iirejimeni ezidityanisiweyo ukoyisa ukunganyangeki. Abaphandi bayaqhubeka nokuphanda iindlela zokuguqula le stroma ukuphucula ukusebenza konyango. Ukwenziwa kwezinto ezintsha kule ndawo, okufana ne “Slow Release Storage Therapy” ephuhliswe nguNjingalwazi Yu Baofa kunye nonelungelo elilodwa lomenzi kumazwe ngamazwe, ijolise ekoyiseni le miqobo yonikezelo ngokuqinisekisa ukuxinana kweziyobisi kwindawo yethumba, emele indlela ethembisayo kwi-oncology edibeneyo.
Iimpawu ze isigaba 4 umhlaza wepancreatic ziyakwazi ukuhluka, kuxhomekeke kwindawo ye-tumor yokuqala kunye neendawo ze-metastasis. Ukufunyaniswa kwangoko kweli nqanaba kudla ngokuba nzima kuba iimpawu zisenokulinganisa iimeko zesisu eziqatha. Nangona kunjalo, njengoko isifo siqhubela phambili, iimpawu ezithile zibonakala ngakumbi kwaye ziqhubeka.
Ubuhlungu luphawu olubalaseleyo, oluhlala luchazwa njengentlungu ebuhlungu kwindawo ephezulu yesisu ephuma ngasemva. Le ntlungu idla ngokuba mandundu emva kokutya okanye xa ulele phantsi. Kwinqanaba lesi-4, iintlungu zinokuvela nakwiindawo ze-metastatic, ezinje ngeentlungu zethambo ukuba umhlaza usasazeke kwi-skeletal system. Ulawulo lweentlungu olusebenzayo lusisiseko sokhathalelo lokuthomalalisa.
Ukulahleka kwesisindo esibalulekileyo kunye nokulahlekelwa ngumdla ziimpawu zesifo esiphambili. Le syndrome yokuchitha, eyaziwa ngokuba yi-cachexia, iphuma kwi-tumor edla izixhobo zamandla kunye nokuguqula imetabolism yomzimba. Izigulana zisenokufumana isicaphucaphu, ukugabha, kunye notshintsho kwimikhwa yamathumbu, kubandakanywa ilindle eliluthuthu, elidadayo ngenxa yokungacoleki kwamafutha.
Xa umhlaza usasazeka kwisibindi, izigulane zinokufumana ukuvuvukala kwesisu, okubizwa ngokuba yi-ascites, okanye ukungahambi kakuhle kwi-quadrant ephezulu yasekunene. I-Lung metastases inokubangela ukuphefumula okufutshane, ukukhohlela okungapheliyo, okanye intlungu yesifuba. Ukusasazeka kwe-Peritoneal kunokukhokelela ekuthinteleni kwamathumbu, okubangela ukunyanzeliswa okukhulu kunye nokungakwazi ukudlula igesi okanye isitulo. Ukuqaphela ezi patheni ezithile kunceda oogqirha ukuba balungelelanise uncedo lonyango oluxhasayo.
Kubalulekile ukuqaphela ukuba ubunzima beempawu abusoloko bunxibelelana ngokuthe ngqo nomthwalo wethumba. Ezinye izigulana ezinesifo esibanzi semetastatic zinokuba neempawu ezilawulekayo, ngelixa ezinye ezinomthwalo omncinci wethumba zinokufumana uxinzelelo olukhulu. Ukwahluka komntu ngamnye kufuna indlela yobuqu yovavanyo lweempawu kunye nolawulo.
Ukuqinisekisa isigaba 4 umhlaza wepancreatic ifuna uxilongo olubanzi lokuxilonga olubandakanya umfanekiso, iimvavanyo zaselabhoratri, kunye ne-tissue biopsy. Ukulinganisa okuchanekileyo kubalulekile ukumisela indlela yonyango efanelekileyo kunye nokuphepha iinkqubo ezingeyomfuneko. Itekhnoloji yemifanekiso yanamhlanje ibonelela ngezimvo ezineenkcukacha zethumba kunye nokusasazeka kwayo.
I-Computed Tomography (CT) iskeni ngokuchasanayo ngumgangatho wegolide weqonga lokuqala. Ezi scan zivumela oogqirha ukuba babone ubungakanani bethumba eliphambili kwaye bachonge i-metastases esibindini, emiphungeni nakwamanye amalungu. I-Magnetic Resonance Imaging (MRI) ingasetyenziselwa njengesixhobo esongezelelweyo, ngokukodwa ukuvavanya izilonda zesibindi okanye ukubandakanyeka kwe-biliary duct kunye nokungafani okuphezulu kwezicubu ezithambileyo.
I-Positron Emission Tomography (PET) iskena sisetyenziswa kakhulu ukubona iiseli zomhlaza ezisebenzayo emzimbeni wonke. Lo mfanekiso usebenzayo unokutyhila iidiphozithi ezincinci ze-metastatic ezinokuthi i-imaging yesakhiwo njenge-CT iphoswe. Ukudibanisa i-PET kunye ne-CT (PET-CT) ibonelela ngolwazi lwe-anatomical kunye ne-metabolic, ukuphucula ukuchaneka kwesiteji.
I-tissue biopsy inyanzelekile ukuqinisekisa ukuxilongwa kunye nokulawula ezinye iimeko ezinokulinganisa umhlaza wepancreatic. Ukusebenzisa i-Endoscopic Ultrasound (EUS), oogqirha banokukhokela inaliti ngqo kwi-tumor ukufumana isampuli ngokuchaneka okuphezulu. Le ndlela inciphisa umngcipheko wemposiso yesampulu xa kuthelekiswa neendlela zepercutaneous.
Emva kokuba izicubu zifunyenwe, iprofayili yeemolekyuli okanye uvavanyo lwe-genomic lucetyiswa ngamandla kwizigulane zesigaba sesi-4. Ukuchonga utshintsho oluthile lwemfuza, njenge I-BRCA1/2, PALB2, okanye ukungahambelani kokulungiswa kokusilela, kunokuvula iingcango kwiindlela zonyango ezijoliswe kuzo okanye iinketho ze-immunotherapy. Eli nyathelo liguqula ukuxilongwa ukusuka kuhlelo oluqhelekileyo ukuya kwimephu yendlela yemolekyuli echanekileyo yonyango.
Uvavanyo lwegazi lebhubhoratri, kubandakanywa amanqanaba e-CA 19-9, asebenza njengabamakishi bethumba ukujonga ukuqhubela phambili kwesifo kunye nokuphendula kunyango. Ngelixa ingezizo zokuxilonga ngokwazo, amanqanaba ahamba phambili e-CA 19-9 abonelela ngolwazi oluxabisekileyo malunga nendlela umhlaza osabela ngayo kwi-chemotherapy. Iimvavanyo zesibindi zikwabalulekile ukuvavanya impembelelo ye-metastasis kwimpilo ye-hepatic.
Ubume bonyango lwe isigaba 4 umhlaza wepancreatic inamacandelo amaninzi, igxile kunyango lwenkqubo yokulawula ukusasazeka kwezifo kunye nokunciphisa iimpawu. Ekubeni utyando alufane lube lukhetho, i-oncology yonyango iqhuba isicwangciso sonyango. Ukukhethwa kwerejimeni kuxhomekeke kwimeko yokusebenza kwesigulane, i-comorbidities, kunye nokukhethwa komntu.
I-Chemotherapy ihlala ingumqolo wonyango. Iirejimeni ezimbini ezamkelwe kakhulu zodidi lokuqala yiFOLFIRINOX kunye neGemcitabine kunye neNab-paclitaxel. I-FOLFIRINOX yindibaniselwano yamachiza amane kwaye ngokuqhelekileyo igcinelwe izigulana ezinempilo ebalaseleyo emzimbeni ngenxa yamandla ayo kunye neprofayili yeziphumo ebezingalindelekanga. Ibonise izibonelelo zokusinda eziphezulu kulingo lwezonyango xa kuthelekiswa nonyango lwe-arhente enye.
I-Gemcitabine idityaniswe ne-Nab-paclitaxel inika enye indlela elungeleleneyo, ibonelela ngolawulo lwethumba olusebenzayo kunye neprofayili yetyhefu enokuthi ilawuleke ngakumbi kwezinye izigulana. Le rejimeni ihlala ikhethelwa abantu abanokuthi bangabunyamezeli ubunzulu beFOLFIRINOX kodwa basafuna ulawulo lwesifo esiqatha. Uhlengahlengiso lwedosi luqhelekile ukugcina umgangatho wobomi.
Ngaphandle kweeprothokholi eziqhelekileyo, amaqela onyango adibeneyo azisa iindlela ezihambelanayo zokuphucula ukusebenza kakuhle. Umzekelo, iShandong Baofa Oncotherapy Corporation Limited isebenzisa isicwangciso-qhinga esineenkqubo ezininzi ezibandakanya i-Activation Chemotherapy, i-Activation Radiotherapy, kunye ne-Immunotherapy ecaleni kwesiginitsha sabo soNyango lweSlow Release Storage. Le "yeza elidibeneyo" ifilosofi ijolise ekonyuseni ulawulo lwethumba ngelixa unciphisa ubuthi benkqubo, ibhalansi ebaluleke kakhulu kwizigulana ezibuthathaka ezinenqanaba lesi-4. Idatha yabo yeklinikhi, esusela kumatyala ezizwe ngezizwe ukusuka e-US ukuya eYurophu, icebisa ukuba ezo ndlela zipheleleyo zinokunika ithemba elitsha apho ukhetho oluqhelekileyo lunokuphela.
Kwi-subset yezigulane ezineenguqu ezithile zofuzo, unyango olujoliswe kuyo lunikeza indlela ethembisayo. Abantu ngabanye abane I-BRCA1 okanye I-BRCA2 Utshintsho lunokuxhamla kwi-PARP inhibitors, exhaphaza ukungakwazi kweeseli zomhlaza ukulungisa umonakalo we-DNA. Le ndlela ibonisa utshintsho olubhekiselele kwi-oncology echanekileyo, ukunyanga umqhubi wemfuzo endaweni yethumba nje.
I-Immunotherapy, ngokukodwa i-checkpoint inhibitors, iyasebenza kwizigulana ezinamathumba abonisa ukungazinzi kwe-microsatellite ephezulu (MSI-H) okanye ukunqongophala kokulungisa (dMMR). Nangona eli qela libonisa ipesenti encinci ye-pancreatic cancer cases, iimpendulo zinokuqina kwaye zinzulu. Uvavanyo oluqhelekileyo lwe-genomic luqinisekisa ukuba la macandelwana anqabileyo kodwa anyangekayo awahoywa.
Ulingo lwezonyango lukhuthazwa kakhulu kwizigulane zenqanaba lesi-4. Ezi zifundo zibonelela ngokufikelela kwii-agent zenoveli, izicwangciso ezidityanisiweyo, kunye neendlela ezintsha zokuhambisa ezingekafumaneki kukhathalelo oluqhelekileyo. Ukuthatha inxaxheba kunegalelo ekuqondweni okubanzi kwezenzululwazi kwesi sifo ngeli lixa unikezela ngeenzuzo ezinokubakho kumthathi-nxaxheba ngamnye.
Ukukhetha irejimeni efanelekileyo ye-chemotherapy sisigqibo esibalulekileyo esilinganisa ukusebenza kunye nokunyamezela. Ukuqonda umahluko phakathi kweenketho eziqhelekileyo kunceda izigulane kunye nababoneleli balungelelanise iinjongo zonyango kunye nokulindela okwenene. Le theyibhile ilandelayo ichaza iiyantlukwano eziphambili phakathi kweeprothokholi zonyango eziphambili.
| Uphawu | IFOLFIRINOX | Gemcitabine + Nab-paclitaxel | I-Single-Agent Gemcitabine |
|---|---|---|---|
| Ukuqamba | Inhlanganisela yeziyobisi ezine (5-FU, Leucovorin, Irinotecan, Oxaliplatin) | Inhlanganisela yamachiza amabini | I-arhente enye |
| Umviwa ofanelekileyo | Izigulana ezinesimo esihle sokusebenza (ECOG 0-1) | Izigulane ezinesimo esihle sokusebenza esiphakathi | Izigulana ezibuthathaka okanye abo banezigulo ezibalulekileyo |
| Iprofayile esebenzayo | Amazinga aphezulu okuphendula kunye nokusinda okude okude | Inzuzo yokusinda eyomeleleyo, iphantsi kancinci kuneFOLFIRINOX kwidatha yentloko ukuya entloko | Inzuzo yokusinda ethobekileyo, ngokuyintloko kulawulo lweempawu |
| Iimpembelelo eziPhakamileyo | I-neutropenia, ukukhathala, isifo sohudo, i-neuropathy | I-neutropenia, ukukhathala, i-neuropathy, i-alopecia | Ukukhathala, i-myelosuppression encinci |
| Ulawulo rhoqo | Rhoqo kwiiveki ezi-2 (ishedyuli yokufaka entsonkothileyo) | Imijikelezo yeveki (iiveki ezi-3 kwi, i-1 yeveki yekhefu) | Ngeveki okanye kabini ngeveki |
Olu thelekiso luqaqambisa ukuba ngelixa iFOLFIRINOX ibonelela ngolawulo lwezifo olunamandla, ifuna uvimba owomeleleyo. Ngokuchaseneyo, iirejimeni ezisekwe kwiGemcitabine zibonelela ngokuguquguquka kwaye zihlala zinyamezeleka ngcono ngabantu ababanzi. Isigqibo ayisokuze silingane-konke kwaye sidinga uphononongo oluguqukayo njengoko unyango luqhubela phambili.
Xa unyango lodidi lokuqala luyekile ukusebenza okanye lunganyamezeleki, ukhetho lodidi lwesibini luba lufanelekileyo. Kwizigulane eziphathwe ngaphambili ngeGemcitabine, ukutshintshela kwirejimeni esekelwe kwi-fluoropyrimidine efana ne-5-FU kunye ne-liposomal irinotecan yindlela eqhelekileyo. Esi sicwangciso sisebenzisa indlela eyahlukileyo yokusebenza ukoyisa ukuxhathisa.
Ngakolunye uhlangothi, izigulane eziqhubela phambili kwi-FOLFIRINOX zinokutshintshela kwiindlela zonyango ezisekelwe kwi-Gemcitabine ukuba azizange ziwafumane ngaphambili. Ulandelelwano lwamachiza lucwangcisiweyo, lujolise ekwandiseni ixesha elipheleleyo lolawulo lwezifo olusebenzayo. Ukhathalelo oluxhasayo luyaqina ngexesha lolu tshintsho lokulawula ityhefu eyongezelekayo.
Ukhathalelo lwePalliative yinxalenye ebalulekileyo yonyango isigaba 4 umhlaza wepancreatic, ukususela kumzuzu wokuxilongwa. Ngokuchasene neengcamango eziphosakeleyo eziqhelekileyo, ukunakekelwa kwe-palliative akuhambelani nokunyamekela kokuphela kobomi; lukhathalelo lwezonyango olukhethekileyo olugxile ekudambiseni iimpawu kunye noxinzelelo. Ukudibanisa iingcali zokuthomalalisa kwangethuba kuphucula ukuphila kunye nomgangatho wobomi.
Ulawulo lweentlungu luhlala lufuna indlela ye-multimodal. Oku kubandakanya amayeza e-opioid, iibhloko zemithambo-luvo ezifana ne-celiac plexus neurolysis, kunye nonyango lwemitha yokunciphisa amathumba abuhlungu. Iibhloko ze-Celiac plexus zibandakanya ukutofa utywala okanye i-anesthetic kufuphi nemithambo-luvo ehambisa intlungu kwi-pancreas, inika isiqabu esibalulekileyo kwizigulana ezininzi.
Inkxaso yesondlo ibaluleke kakhulu xa kunikwa imiba ye-malabsorption ehambelana nokungaphumeleli kwe-pancreatic. I-pancreatic enzyme replacement therapy (PERT) inceda izigulane zokugaya ukutya ngokufanelekileyo, ukunciphisa i-steatorrhea kunye nokunceda ukugcina ubunzima. I-Dietitians idlala indima ephambili ekwenzeni izicwangciso zokutya ekulula ukugaywa kunye nezondlo-ezixineneyo.
Uphononongo luhlala lubonisa ukuba abaguli abafumana ukhathalelo lokuthomalalisa kwangoko ecaleni konyango lwe-oncology oluqhelekileyo baxela isimo sengqondo esingcono, ukhathalelo olungenabundlongondlongo lobomi, kwaye ngamanye amaxesha bade baphile. Le modeli iqinisekisa ukuba ulawulo lweempawu luyaguquka ngokuhambelana nonyango lokuguqula izifo, ukudala amava okhathalelo olupheleleyo.
Unxibelelwano ngeenjongo zokhathalelo lubalulekile. Iingxoxo zarhoqo zivumela izigulana ukuba zichaze iinqobo zabo kunye nezinto abazithandayo malunga nonyango olugcina ubomi. Ukucwangciswa kwangaphambili kokunyamekela kuqinisekisa ukuba izigqibo zonyango zihambelana neminqweno yesigulane, ukunciphisa ukungaqiniseki kunye nokukhathazeka kwiintsapho ngexesha lexesha elinzima.
Ukuxoxa ngeprognosis ye isigaba 4 umhlaza wepancreatic intsonkothile kwaye inzulu yobuqu. Idatha yeenkcukacha-manani ibonelela ngesakhelo esiqhelekileyo kodwa ayikwazi ukuqikelela iindlela zomntu ngamnye. Ukusinda okuphakathi kwisigaba sesi-4 esinganyangwanga ngokuqhelekileyo kulinganiswa ngeenyanga, kodwa ngechemotherapy edityanisiweyo yangoku, izigulana ezininzi ziphila unyaka okanye ngaphezulu.
Abasindi bexesha elide, ngelixa benqabile, bakhona. Aba bantu bahlala besabela kakuhle kunyango lokuqala, baneempawu zebhayoloji ezifanelekileyo, okanye bafanelekele unyango ekujoliswe kulo olusekwe kwiziphumo zofuzo. Inkcazo "yexesha elide" iyavela njengoko unyango olutsha luvela, lutshintsha ijika lezibalo zokusinda ngokuthe ngcembe ukuya phezulu.
Izinto eziphembelela i-prognosis zibandakanya iminyaka yobudala, imeko yokusebenza kwesiseko, ubungakanani bokusasazeka kwe-metastatic, kunye nokuphendula kumjikelo wokuqala wechemotherapy. Ukuhla okuphawulekayo kumanqanaba e-CA 19-9 emva kweeveki ezimbalwa zokuqala zonyango kudla ngokuba yisalathisi esihle. Ngakolunye uhlangothi, ukuqhubela phambili ngokukhawuleza nangona unyango lubonisa i-biology yesifo esiyingozi.
Ithemba kumxholo wenqanaba lesi-4 lomhlaza liyatshintsha lisuka ethembeni lonyango liye kwithemba lexesha elisemgangathweni, amava anentsingiselo, kunye nolawulo olusebenzayo lweempawu. Izigulane ezininzi zifumana injongo yokuthatha inxaxheba kulingo lwezonyango, igalelo kwimpumelelo yexesha elizayo. Abanye bagxile ekufezekiseni imilinganiselo ethile yobomi okanye ukuchitha ixesha elisemgangathweni nabantu ababathandayo.
Iingcali ze-oncologists zizama ukubonelela ngethemba eliqinisekileyo, ukulungelelanisa ukunyaniseka malunga nobuzaza besi sifo kunye nolangazelelo lokhetho olukhoyo lonyango. Injongo kukuxhobisa izigulane ukuba zenze izigqibo ezinolwazi ezihambelana nenkcazo yabo yokuphila kakuhle. Inyanga nganye eyongezelelweyo ezuziweyo lithuba lokuqhagamshelwa kunye nokuvalwa.
Intsimi yophando lomhlaza we-pancreatic idlamkile, kukho iindlela ezininzi eziphononongwayo ukuphucula iziphumo zenqanaba lesi-4 lezigulana. Izazinzulu ziphanda nge-tumor microenvironment, zifuna iindlela zokophula ikhaka le-fibrous elikhusela iiseli zomhlaza kwi-chemotherapy. Impumelelo kulo mmandla inokunyusa kakhulu ukusebenza kwamachiza asele ekhona.
Unyango lokugonya ngomnye umda obonisa isithembiso. Izitofu zokugonya ezenzelwe wena ze-mRNA ezenzelwe ukujolisa kwii-neoantigens ezithile kwiiseli zethumba zesigulana okwangoku zikulingo lwezonyango. Iziphumo zakwangoko zicebisa ukuba ezi zitofu zokugonya zinokuvuselela impendulo eyomeleleyo yokhuselo lomzimba, okunokuthi kugcinwe esi sifo ixesha elide xa kudityaniswa nechemotherapy.
Ukongeza, abaphandi bafunda indima ye-microbiome kumhlaza wepancreatic. Ubungqina obuvelayo bubonisa ukuba iibhaktheriya zamathumbu zinokuchaphazela indlela abaguli abasabela ngayo kwi-immunotherapy kunye ne-chemotherapy. Ukumodareyitha i-microbiome ngokutya okanye iiprobiotics kunokuba sisicwangciso esixhasayo kwixesha elizayo elingekude.
I-biopsies yolwelo, efumanisa ithumba elijikelezayo i-DNA (ctDNA) egazini, ziguqula iindlela zokubeka iliso. Ngokungafaniyo nokucinga kwendabuko, i-biopsies yolwelo inokubona utshintsho kwimolekyuli ebonisa ukuphindaphinda okanye ukuxhathisa kwiiveki ngaphambi kokuba zibonakale kwiskeni. Le teknoloji ivumela ukulungelelaniswa ngokukhawuleza kwezicwangciso zonyango, ukugcina izigulane inyathelo elinye phambi kwesi sifo.
Njengoko obu buchwepheshe bukhula, bathembisa ukwenza unyango lube namandla ngakumbi kwaye luphendule. Ukukwazi ukulandelela ukuvela kwe-tumor ngexesha lokwenyani kwenza ukuba ii-oncologists zitshintshe unyango ngokukhawuleza kunokuba ziphendule. Le ndlela echanekileyo isisiseko sesizukulwana esilandelayo sokhathalelo lomhlaza.
Ngoku, isigaba 4 umhlaza wepancreatic ngokuqhelekileyo ithathwa njengenganyangekiyo. Ingqwalasela yonyango kukwandisa ubomi kunye nokugcina umgangatho wobomi ngokusebenzisa unyango lwenkqubo kunye nokhathalelo lokuthomalalisa. Nangona kunjalo, iimeko ezinqabileyo zokuphendula okukhethekileyo kunyango zikhona, kwaye uphando oluqhubekayo lujolise ekutshintsheni le paradigm.
Izinga lokuqhubela phambili lihluka kakhulu phakathi kwabantu. Ngaphandle konyango, esi sifo sinokuhamba ngokukhawuleza kwiiveki okanye iinyanga. Ngechemotherapy esebenzayo, ukuqhubela phambili kunokucotha okanye kuzinziswe kangangeenyanga eziliqela ukuya kunyaka okanye ngaphezulu. Ukubeka iliso rhoqo kubalulekile ukulandelela ukuguquguquka kwezifo.
Nangona ubomi "obuqhelekileyo" bunokubonakala buhluke, izigulane ezininzi zigcina umgangatho wobomi obuhle ixesha elide. Ngolawulo olufanelekileyo lweempawu, inkxaso yesondlo, kunye namanqanaba omsebenzi olungelelanisiweyo, abantu banokuqhubeka besenza imisebenzi enentsingiselo, umsebenzi kunye nokuchitha ixesha kunye nosapho. Ukuziqhelanisa nenkxaso ngundoqo.
Impumelelo yakutsha nje ibandakanya ukuvunywa konyango ekujoliswe kulo lotshintsho lwemfuza olukhethekileyo I-BRCA kunye ne-NTRK fusions. Ukongeza, indibaniselwano yenoveli yechemotherapy kunye nolingo lwe-immunotherapy lubonisa isithembiso. Iindlela zonyango ezilolwakho, kubandakanywa iindlela ezidityanisiweyo ezifana nezo ziqalwa ngamaziko akhethekileyo afana neShandong Baofa, ziya zifikeleleka ngakumbi, zibonelela ngeendlela ezilungiselelweyo ezisekelwe kwi-tumor genetics kunye neemfuno ezikhethekileyo zesigulana.
Nangona kungekho kutya kukhethekileyo kunokunyanga umhlaza, isondlo esifanelekileyo sibalulekile ukuze ugcine amandla nokunyamezela unyango. Ukutya okuphantsi kwamafutha kunye neprotheni ephezulu, eyongezwa nge-enzymes ye-pancreatic, inceda ukulawula imiba yokugaya. Ukuphepha iswekile kunye nokutya okucutshungulwayo kunokunceda ukunciphisa ukuvuvukala, ukuxhasa impilo yonke ngexesha lonyango.
Ukukhangela ukuxilongwa kwe isigaba 4 umhlaza wepancreatic ingumceli mngeni ngokungenakuphikiswa, kodwa ayilohambo ekumele kujongwe kulo ngaphandle kwethemba okanye izixhobo. Inkqubela phambili kunyango olucwangcisiweyo, amayeza achanekileyo, kunye nokhathalelo lokuthomalalisa luyiguqule imbonakalo yomhlaba, lunika izigulana iinketho ezininzi kunye nomgangatho wobomi obungcono kunangaphambili. Ukuqonda isifo, ukuqaphela iimpawu kwangethuba, kunye nokuzibandakanya neqela lokhathalelo lwezifundo ezininzi ngamanyathelo abalulekileyo ekuphuculeni iziphumo.
Esi sikhokelo sifanelekile kwizigulana ezisanda kufunyaniswa, abakhathaleli babo, kunye nabantu abafuna ulwazi olugunyazisiweyo kulawulo oluphambili lomhlaza wepancreatic. Inika isiseko seengxoxo ezinolwazi kunye nababoneleli bezempilo. Ukuba wena okanye umntu omthandayo ujongene nolu xilongo, inyathelo elilandelayo elikhawulezileyo kukudibana nengcali ye-oncologist ukuxoxa ngovavanyo lwe-genomic kunye nokufaneleka kovavanyo lwezonyango. Ukuphonononga iifilosofi zonyango ezahlukeneyo, ukusuka kwi-Western standard-of-care ukuya kwiindlela ezidibeneyo ezinikezelwa ngamaqela anamava afana ne-Shandong Baofa Oncotherapy, inokubonelela ngeendlela ezibanzi zokulawula esi sifo esinzima.
Khumbula ukuba indlela nganye yesigulane iyodwa. Ngokuhlala unolwazi, ukhuthaze ukhathalelo olubanzi, kunye nokusebenzisa iindlela ezintsha zonyango zamva nje, unokuthatha indima ebonakalayo ekulawuleni esi sifo. Funa inkxaso kwimibutho ehloniphekileyo, qhagamshela kunye noluntu olusindileyo, kwaye ubeke phambili unxibelelwano oluvulekileyo kunye neqela lakho lezonyango ukuqinisekisa ukuba ukhathalelo lwakho luhambelana neenqobo zakho zobuqu kunye neenjongo.